Olaparib for Metastatic Breast Cancer in Patients with a Germline <i>BRCA</i> Mutation

Memorial Sloan Kettering Cancer Center, Chinese Academy of Medical Sciences & Peking Union Medical College, National Cancer Center, Seoul National University Hospital, Gdańsk Medical University, University of Pennsylvania, Osaka National Hospital, Institut Gustave Roussy, Jilin University, First Hospital of Jilin University, Beth Israel Deaconess Medical Center, The Christie NHS Foundation Trust, AstraZeneca (Japan), AstraZeneca (Singapore), University of Padua, Istituto Oncologico Veneto